Cardiac amyloidosis—interdisciplinary approach to diagnosis and therapy View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-06-08

AUTHORS

A. Hänselmann, D. Berliner, J. Bauersachs, U. Bavendiek

ABSTRACT

The vast majority of cardiac amyloidosis (CA) cases are caused by light chain (AL) or transthyretin (ATTR) amyloidosis. The latter is divided into hereditary (ATTRv) and wild-type forms (ATTRwt). The incidence of ATTRwt amyloidosis has significantly increased, particularly due to the improved diagnosis of cardiac manifestations, with relevant proportions in patient populations with heart failure (HF) and preserved ejection fraction (HFpEF). Cardiac amyloidosis should be suspected in HF with indicative clinical scenarios/“red flags” with typical signs of CA in echocardiography. Further noninvasive imaging (cardiovascular magnetic resonance imaging, scintigraphy) and specific laboratory diagnostics are important for the diagnosis and typing of CA into the underlying main forms of ATTR and AL amyloidosis. The histopathologic analysis of an endomyocardial biopsy is necessary if noninvasive diagnostic methods do not enable reliable typing of CA. This is crucial for initiating specific therapy. Therapy of HF in CA is largely limited to the use of diuretics in the absence of evidence on the benefit of classic HF therapy with neurohormonal modulators. Innovative therapies have been developed for amyloidosis with improvement in organ protection, prognosis, and quality of life. These include specific cytoreductive therapies for monoclonal light-chain disease in AL amyloidosis and pharmacologic stabilization or inhibition of transthyretin expression in ATTR amyloidosis. Since the CA underlying amyloidosis is a systemic disease also affecting other organ systems, close interdisciplinary cooperation is crucial for rapid and effective diagnosis and therapy. More... »

PAGES

324-331

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00059-022-05122-w

DOI

http://dx.doi.org/10.1007/s00059-022-05122-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1148517983

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35674775


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amyloid Neuropathies, Familial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiomyopathies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin Light-chain Amyloidosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prealbumin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke Volume", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "H\u00e4nselmann", 
        "givenName": "A.", 
        "id": "sg:person.010625116255.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010625116255.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berliner", 
        "givenName": "D.", 
        "id": "sg:person.0771601356.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771601356.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bauersachs", 
        "givenName": "J.", 
        "id": "sg:person.01152455105.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152455105.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amyloidosezentrum Niedersachsen, Hannover Medical School, Hannover, Germany", 
          "id": "http://www.grid.ac/institutes/grid.10423.34", 
          "name": [
            "Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany", 
            "Amyloidosezentrum Niedersachsen, Hannover Medical School, Hannover, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bavendiek", 
        "givenName": "U.", 
        "id": "sg:person.0727204757.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727204757.35"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10072-020-04889-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1132633114", 
          "https://doi.org/10.1007/s10072-020-04889-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-020-01799-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1134670889", 
          "https://doi.org/10.1007/s00392-020-01799-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-013-7051-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012089411", 
          "https://doi.org/10.1007/s00415-013-7051-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12350-019-01760-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1120691098", 
          "https://doi.org/10.1007/s12350-019-01760-6"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-06-08", 
    "datePublishedReg": "2022-06-08", 
    "description": "The vast majority of cardiac amyloidosis (CA) cases are caused by light chain (AL) or transthyretin (ATTR) amyloidosis. The latter is divided into hereditary (ATTRv) and wild-type forms (ATTRwt). The incidence of ATTRwt amyloidosis has significantly increased, particularly due to the improved diagnosis of cardiac manifestations, with relevant proportions in patient populations with heart failure (HF) and preserved ejection fraction (HFpEF). Cardiac amyloidosis should be suspected in HF with indicative clinical scenarios/\u201cred flags\u201d with typical signs of CA in echocardiography. Further noninvasive imaging (cardiovascular magnetic resonance imaging, scintigraphy) and specific laboratory diagnostics are important for the diagnosis and typing of CA into the underlying main forms of ATTR and AL amyloidosis. The histopathologic analysis of an endomyocardial biopsy is necessary if noninvasive diagnostic methods do not enable reliable typing of CA. This is crucial for initiating specific therapy. Therapy of HF in CA is largely limited to the use of diuretics in the absence of evidence on the benefit of classic HF therapy with neurohormonal modulators. Innovative therapies have been developed for amyloidosis with improvement in organ protection, prognosis, and quality of life. These include specific cytoreductive therapies for monoclonal light-chain disease in AL amyloidosis and pharmacologic stabilization or inhibition of transthyretin expression in ATTR amyloidosis. Since the CA underlying amyloidosis is a\u00a0systemic disease also affecting other organ systems, close interdisciplinary cooperation is crucial for rapid and effective diagnosis and therapy.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00059-022-05122-w", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1087175", 
        "issn": [
          "0340-9937", 
          "1615-6692"
        ], 
        "name": "Herz", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "keywords": [
      "heart failure", 
      "AL amyloidosis", 
      "therapy of HF", 
      "use of diuretics", 
      "quality of life", 
      "light chain disease", 
      "noninvasive diagnostic method", 
      "HF therapy", 
      "neurohormonal modulators", 
      "cardiac manifestations", 
      "ejection fraction", 
      "endomyocardial biopsy", 
      "cytoreductive therapy", 
      "close interdisciplinary cooperation", 
      "patient population", 
      "organ protection", 
      "systemic disease", 
      "specific therapy", 
      "cardiac amyloidosis", 
      "histopathologic analysis", 
      "ATTRwt amyloidosis", 
      "pharmacologic stabilization", 
      "transthyretin amyloidosis", 
      "innovative therapies", 
      "ATTR amyloidosis", 
      "amyloidosis cases", 
      "typical signs", 
      "therapy", 
      "relevant proportion", 
      "amyloidosis", 
      "absence of evidence", 
      "organ systems", 
      "diagnosis", 
      "noninvasive imaging", 
      "laboratory diagnostics", 
      "improved diagnosis", 
      "diagnostic methods", 
      "monoclonal light-chain diseases", 
      "transthyretin expression", 
      "effective diagnosis", 
      "disease", 
      "light chain", 
      "reliable typing", 
      "typing", 
      "vast majority", 
      "interdisciplinary cooperation", 
      "echocardiography", 
      "diuretics", 
      "biopsy", 
      "prognosis", 
      "incidence", 
      "wild-type form", 
      "manifestations", 
      "ATTR", 
      "inhibition", 
      "signs", 
      "imaging", 
      "failure", 
      "majority", 
      "population", 
      "expression", 
      "proportion", 
      "evidence", 
      "modulator", 
      "main forms", 
      "absence", 
      "cases", 
      "life", 
      "benefits", 
      "improvement", 
      "protection", 
      "use", 
      "diagnostics", 
      "quality", 
      "form", 
      "Ca", 
      "fraction", 
      "analysis", 
      "flags", 
      "stabilization", 
      "method", 
      "approach", 
      "system", 
      "cooperation", 
      "chain"
    ], 
    "name": "Cardiac amyloidosis\u2014interdisciplinary approach to diagnosis and therapy", 
    "pagination": "324-331", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1148517983"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00059-022-05122-w"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35674775"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00059-022-05122-w", 
      "https://app.dimensions.ai/details/publication/pub.1148517983"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_947.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00059-022-05122-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05122-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05122-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05122-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00059-022-05122-w'


 

This table displays all metadata directly associated to this object as RDF triples.

217 TRIPLES      21 PREDICATES      122 URIs      110 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00059-022-05122-w schema:about N0c5dffeb50d7449791fcf9352a786a5a
2 N21d540af7d7b4e30b9268c21998474e6
3 N2683d54402734903be3247154dfad024
4 N3717447b5427422d8c19f3d054d0f11a
5 N98eebb1e2eff45f29f6a3124c43d356c
6 Na1bbba2e08794f4da1b0473cd7ca7c24
7 Na777d63e8cad4b3f866f8f65c03fadd5
8 Nd1c05ef266804f03ab816a8c5d027a6d
9 anzsrc-for:11
10 anzsrc-for:1102
11 schema:author N49ac4c8e93e64a779f385b758614ee0d
12 schema:citation sg:pub.10.1007/s00392-020-01799-3
13 sg:pub.10.1007/s00415-013-7051-7
14 sg:pub.10.1007/s10072-020-04889-2
15 sg:pub.10.1007/s12350-019-01760-6
16 schema:datePublished 2022-06-08
17 schema:datePublishedReg 2022-06-08
18 schema:description The vast majority of cardiac amyloidosis (CA) cases are caused by light chain (AL) or transthyretin (ATTR) amyloidosis. The latter is divided into hereditary (ATTRv) and wild-type forms (ATTRwt). The incidence of ATTRwt amyloidosis has significantly increased, particularly due to the improved diagnosis of cardiac manifestations, with relevant proportions in patient populations with heart failure (HF) and preserved ejection fraction (HFpEF). Cardiac amyloidosis should be suspected in HF with indicative clinical scenarios/“red flags” with typical signs of CA in echocardiography. Further noninvasive imaging (cardiovascular magnetic resonance imaging, scintigraphy) and specific laboratory diagnostics are important for the diagnosis and typing of CA into the underlying main forms of ATTR and AL amyloidosis. The histopathologic analysis of an endomyocardial biopsy is necessary if noninvasive diagnostic methods do not enable reliable typing of CA. This is crucial for initiating specific therapy. Therapy of HF in CA is largely limited to the use of diuretics in the absence of evidence on the benefit of classic HF therapy with neurohormonal modulators. Innovative therapies have been developed for amyloidosis with improvement in organ protection, prognosis, and quality of life. These include specific cytoreductive therapies for monoclonal light-chain disease in AL amyloidosis and pharmacologic stabilization or inhibition of transthyretin expression in ATTR amyloidosis. Since the CA underlying amyloidosis is a systemic disease also affecting other organ systems, close interdisciplinary cooperation is crucial for rapid and effective diagnosis and therapy.
19 schema:genre article
20 schema:isAccessibleForFree false
21 schema:isPartOf N38befb24f29249058343c003a6571235
22 N7db116f08a2446d795832f6b21998092
23 sg:journal.1087175
24 schema:keywords AL amyloidosis
25 ATTR
26 ATTR amyloidosis
27 ATTRwt amyloidosis
28 Ca
29 HF therapy
30 absence
31 absence of evidence
32 amyloidosis
33 amyloidosis cases
34 analysis
35 approach
36 benefits
37 biopsy
38 cardiac amyloidosis
39 cardiac manifestations
40 cases
41 chain
42 close interdisciplinary cooperation
43 cooperation
44 cytoreductive therapy
45 diagnosis
46 diagnostic methods
47 diagnostics
48 disease
49 diuretics
50 echocardiography
51 effective diagnosis
52 ejection fraction
53 endomyocardial biopsy
54 evidence
55 expression
56 failure
57 flags
58 form
59 fraction
60 heart failure
61 histopathologic analysis
62 imaging
63 improved diagnosis
64 improvement
65 incidence
66 inhibition
67 innovative therapies
68 interdisciplinary cooperation
69 laboratory diagnostics
70 life
71 light chain
72 light chain disease
73 main forms
74 majority
75 manifestations
76 method
77 modulator
78 monoclonal light-chain diseases
79 neurohormonal modulators
80 noninvasive diagnostic method
81 noninvasive imaging
82 organ protection
83 organ systems
84 patient population
85 pharmacologic stabilization
86 population
87 prognosis
88 proportion
89 protection
90 quality
91 quality of life
92 relevant proportion
93 reliable typing
94 signs
95 specific therapy
96 stabilization
97 system
98 systemic disease
99 therapy
100 therapy of HF
101 transthyretin amyloidosis
102 transthyretin expression
103 typical signs
104 typing
105 use
106 use of diuretics
107 vast majority
108 wild-type form
109 schema:name Cardiac amyloidosis—interdisciplinary approach to diagnosis and therapy
110 schema:pagination 324-331
111 schema:productId N01014fbfc74c4fff884d31b4a68fbd69
112 N5a4d8dbdd9c543ee84af4a49c0e427fd
113 Nd519687a6e5540a8ad3c4cddf11d3ef8
114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1148517983
115 https://doi.org/10.1007/s00059-022-05122-w
116 schema:sdDatePublished 2022-09-02T16:08
117 schema:sdLicense https://scigraph.springernature.com/explorer/license/
118 schema:sdPublisher N221bf31547524d40988487a1fb34b12b
119 schema:url https://doi.org/10.1007/s00059-022-05122-w
120 sgo:license sg:explorer/license/
121 sgo:sdDataset articles
122 rdf:type schema:ScholarlyArticle
123 N01014fbfc74c4fff884d31b4a68fbd69 schema:name pubmed_id
124 schema:value 35674775
125 rdf:type schema:PropertyValue
126 N0c5dffeb50d7449791fcf9352a786a5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Quality of Life
128 rdf:type schema:DefinedTerm
129 N21d540af7d7b4e30b9268c21998474e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Prealbumin
131 rdf:type schema:DefinedTerm
132 N221bf31547524d40988487a1fb34b12b schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 N2683d54402734903be3247154dfad024 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Immunoglobulin Light-chain Amyloidosis
136 rdf:type schema:DefinedTerm
137 N3717447b5427422d8c19f3d054d0f11a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Heart Failure
139 rdf:type schema:DefinedTerm
140 N38befb24f29249058343c003a6571235 schema:volumeNumber 47
141 rdf:type schema:PublicationVolume
142 N49ac4c8e93e64a779f385b758614ee0d rdf:first sg:person.010625116255.12
143 rdf:rest Nc3115b076dd44cd4ad1304c95d315f03
144 N5a4d8dbdd9c543ee84af4a49c0e427fd schema:name dimensions_id
145 schema:value pub.1148517983
146 rdf:type schema:PropertyValue
147 N6c7edd9453644ecf95eeb90d30bf4bc8 rdf:first sg:person.0727204757.35
148 rdf:rest rdf:nil
149 N6d4978873c1c4b2b95bd50042f61b77d rdf:first sg:person.01152455105.32
150 rdf:rest N6c7edd9453644ecf95eeb90d30bf4bc8
151 N7db116f08a2446d795832f6b21998092 schema:issueNumber 4
152 rdf:type schema:PublicationIssue
153 N98eebb1e2eff45f29f6a3124c43d356c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Amyloid Neuropathies, Familial
155 rdf:type schema:DefinedTerm
156 Na1bbba2e08794f4da1b0473cd7ca7c24 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Humans
158 rdf:type schema:DefinedTerm
159 Na777d63e8cad4b3f866f8f65c03fadd5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Stroke Volume
161 rdf:type schema:DefinedTerm
162 Nc3115b076dd44cd4ad1304c95d315f03 rdf:first sg:person.0771601356.05
163 rdf:rest N6d4978873c1c4b2b95bd50042f61b77d
164 Nd1c05ef266804f03ab816a8c5d027a6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Cardiomyopathies
166 rdf:type schema:DefinedTerm
167 Nd519687a6e5540a8ad3c4cddf11d3ef8 schema:name doi
168 schema:value 10.1007/s00059-022-05122-w
169 rdf:type schema:PropertyValue
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
174 schema:name Cardiorespiratory Medicine and Haematology
175 rdf:type schema:DefinedTerm
176 sg:journal.1087175 schema:issn 0340-9937
177 1615-6692
178 schema:name Herz
179 schema:publisher Springer Nature
180 rdf:type schema:Periodical
181 sg:person.010625116255.12 schema:affiliation grid-institutes:grid.10423.34
182 schema:familyName Hänselmann
183 schema:givenName A.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010625116255.12
185 rdf:type schema:Person
186 sg:person.01152455105.32 schema:affiliation grid-institutes:grid.10423.34
187 schema:familyName Bauersachs
188 schema:givenName J.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152455105.32
190 rdf:type schema:Person
191 sg:person.0727204757.35 schema:affiliation grid-institutes:grid.10423.34
192 schema:familyName Bavendiek
193 schema:givenName U.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727204757.35
195 rdf:type schema:Person
196 sg:person.0771601356.05 schema:affiliation grid-institutes:grid.10423.34
197 schema:familyName Berliner
198 schema:givenName D.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771601356.05
200 rdf:type schema:Person
201 sg:pub.10.1007/s00392-020-01799-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134670889
202 https://doi.org/10.1007/s00392-020-01799-3
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/s00415-013-7051-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012089411
205 https://doi.org/10.1007/s00415-013-7051-7
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/s10072-020-04889-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1132633114
208 https://doi.org/10.1007/s10072-020-04889-2
209 rdf:type schema:CreativeWork
210 sg:pub.10.1007/s12350-019-01760-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1120691098
211 https://doi.org/10.1007/s12350-019-01760-6
212 rdf:type schema:CreativeWork
213 grid-institutes:grid.10423.34 schema:alternateName Amyloidosezentrum Niedersachsen, Hannover Medical School, Hannover, Germany
214 Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
215 schema:name Amyloidosezentrum Niedersachsen, Hannover Medical School, Hannover, Germany
216 Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany
217 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...